首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

2075233

寡核苷酸合成市場：依設備與服務、技術、核酸、應用、最終用戶和地區分類

Oligonucleotide Synthesis Market,By Equipment and Services, By Technology, By Nucleic Acid, By Application, By End User, By Geography

出版日期: 2026年04月29日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

寡核苷酸合成市場預計在2026年達到52.1億美元，預計2033年將達到108.9億美元。預計從2026年到2033年，其複合年成長率將達到11.1%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	52.1億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	11.10%	2033年市場規模預測：	108.9億美元

寡核苷酸常被用作聚合酵素鏈鎖反應(PCR)、PCR 檢測和生物相關基因檢測的引子。反義寡核苷酸透過抑制 mRNA 加工和翻譯來降低蛋白質合成水平。寡核苷酸的其他應用包括 DNA定序、DNA 微陣列、螢光雜合反應(FISH) 和核酸適配體。此外，隨著許多製藥公司致力於開發基於核酸的療法，對寡核苷酸的需求正在不斷成長。因此，市場新進業者正致力於擴大其生產設施，預計這將推動預測期內的市場成長。例如，2020 年 8 月，安捷倫科技公司宣布擴建其位於科羅拉多弗雷德里克市的先進生產設施，該設施用於開發和生產具有潛在應用價值的寡核苷酸，這些寡核苷酸可用於治療 COVID-19、心血管疾病、癌症、罕見疾病、感染疾病和其他疾病。

市場動態：

各大公司正致力於各種非內部成長策略，例如合作、夥伴關係和協議，預計這些策略將在預測期內推動全球寡核苷酸合成市場的成長。例如，2020年8月5日，藥物研發公司Evotec SE與藥物研發公司Sekarna Pharmaceuticals GmbH & Co. KG達成策略合作，共同開發反義寡核苷酸療法。

此外，2019 年 11 月，胜肽和設備製造公司 CSBio 與離子交換樹脂和吸附/分離樹脂供應商 Sunresin 簽訂了聯合研究協議，以開發商業規模寡核苷酸合成最佳化的聚苯乙烯樹脂。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數對全球寡核苷酸合成市場的主要參與者進行了分析：公司概況、財務績效、產品系列、市場地位、分銷策略、主要發展、策略和未來計劃。
本報告提供的見解將有助於企業負責人和經營團隊就未來的產品發布、市場擴張和行銷策略做出明智的決策。
這份全球寡核苷酸合成市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等產業相關人員。
相關人員可以透過利用全球寡核苷酸合成市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第10章競爭格局

公司簡介
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Twist Bioscience
- STA Pharmaceutical Co. Ltd.
- KINOVATE LIFE SCIENCES
- CUSABIO TECHNOLOGY LLC
- Synbio Technologies
- GENEWIZ
- Agilent Technologies, Inc.
- Maravai LifeSciences Holdings, Inc.
- Biogen
- Eurofins Scientific
- Sarepta Therapeutics, Inc.
- LGC Limited
- Kaneka Corporation
- Biotage
- Nitto Denko Corporation

第11章

參考
調查方法

簡介目錄

Product Code: CMI4257

Oligonucleotide Synthesis Market is estimated to be valued at USD 5.21 Bn in 2026 and is expected to reach USD 10.89 Bn by 2033, growing at a compound annual growth rate (CAGR) of 11.1% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 5.21 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	11.10%	2033 Value Projection:	USD 10.89 Bn

Oligonucleotides are commonly used as primers for polymerase chain reaction (PCR), PCR assays, and panels for biologically related genes. Antisense oligonucleotides are used to reduce levels of protein synthesis by inhibiting mRNA processing or translation. Other uses of oligonucleotides include DNA sequencing, DNA microarrays, fluorescence in situ hybridization (FISH), and nucleic acid aptamers. Moreover, many pharmaceutical companies are focusing on developing nucleic acid-based therapeutics due to which the demand of oligonucleotide is increasing. Hence, market players are focusing on expanding their manufacturing facilities, which is expected to boost the market growth over the forecast period. For instance, in August 2020, Agilent Technologies Inc., announced the expansion of its state-of-the-art production facility in Frederick, Colorado, which develops manufactures oligos that hold potential to be used as treatments for diseases such as COVID-19, cardiovascular disease, cancer, rare and infectious diseases, and other conditions.

Market Dynamics:

Key players are focusing on various inorganic growth strategies such as collaborations, partnerships and agreements, which is expected to propel the growth of the global oligonucleotide synthesis market during the forecast period. For instance, on August 05, 2020, Evotec SE, a drug discovery and development company entered into a strategic partnership with Secarna Pharmaceuticals GmbH & Co. KG, a drug discovery company, for the development of antisense oligonucleotide therapies.

Moreover, in November 2019, CSBio, a peptide and instrumentation manufacturing company entered into a collaboration with Sunresin, a supplier of ion exchange resin and absorption & separation resin for the development of an optimized polystyrene resin for commercial scale oligonucleotide synthesis.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global oligonucleotide synthesis market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans.
Key companies covered as a part of this study include Thermo Fisher Scientific, Sigma-Aldrich Corporation, GE Healthcare, Integrated DNA Technologies, Inc., TriLink BioTechnologies, Inc, BioAutomation Corporation, Twist Bioscience, Shanghai SynTheAll Pharmaceutical Co., CUSABIO Technology LLC, Synbio Technologies, GENEWIZ, Eurofins Scientific, Agilent Technologies, Kaneka Eurogentec S.A., and LGC, Biosearch Technologies
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future product launches, market expansion, and marketing tactics
The global oligonucleotide synthesis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global oligonucleotide synthesis market.

Detailed Segmentation:

Global Oligonucleotide Synthesis Market, By Equipment & Services (Revenue, USD Bn, 2021 - 2033)
Equipment/Synthesizer
Reagents
Services
- Oligo Synthesis
- Modification
- Purification
Global Oligonucleotide Synthesis Market, By Technology (Revenue, USD Bn, 2021 - 2033)
Column-based
Microarray-based
Global Oligonucleotide Synthesis Market, By Nucleic Acid Type (Revenue, USD Bn, 2021 - 2033)
DNA
RNA
Global Oligonucleotide Synthesis Market, By Application (Revenue, USD Bn, 2021 - 2033)
Drug Discovery
Therapeutics
Global Oligonucleotide Synthesis Market, By End User (Revenue, USD Bn, 2021 - 2033)
Academic Research Institutes
Diagnostic Laboratories
Pharmaceutical-Biotechnology Companies
Global Oligonucleotide Synthesis Market, By Region (Revenue, USD Bn, 2021 - 2033)
North America
- By Equipment & Services
  - Equipment/Synthesizer
  - Reagents
  - Services
- By Technology
  - Column-based
  - Microarray-based
- By Nucleic Acid Type
  - DNA
  - RNA
- By Application
  - Drug Discovery
  - Therapeutics
- By End User
  - Academic Research Institutes
  - Diagnostic Laboratories
  - Pharmaceutical-Biotechnology Companies
- By Country:
  - U.S.
  - Canada
Latin America
- By Equipment & Services
  - Equipment/Synthesizer
  - Reagents
  - Services
- By Technology
  - Column-based
  - Microarray-based
- By Nucleic Acid Type
  - DNA
  - RNA
- By Application
  - Drug Discovery
  - Therapeutics
- By End User
  - Academic Research Institutes
  - Diagnostic Laboratories
  - Pharmaceutical-Biotechnology Companies
- By Country:
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- By Equipment & Services
  - Equipment/Synthesizer
  - Reagents
  - Services
- By Technology
  - Column-based
  - Microarray-based
- By Nucleic Acid Type
  - DNA
  - RNA
- By Application
  - Drug Discovery
  - Therapeutics
- By End User
  - Academic Research Institutes
  - Diagnostic Laboratories
  - Pharmaceutical-Biotechnology Companies
- By Country:
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- By Equipment & Services
  - Equipment/Synthesizer
  - Reagents
  - Services
- By Technology
  - Column-based
  - Microarray-based
- By Nucleic Acid Type
  - DNA
  - RNA
- By Application
  - Drug Discovery
  - Therapeutics
- By End User
  - Academic Research Institutes
  - Diagnostic Laboratories
  - Pharmaceutical-Biotechnology Companies
- By Country:
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- By Equipment & Services
  - Equipment/Synthesizer
  - Reagents
  - Services
- By Technology
  - Column-based
  - Microarray-based
- By Nucleic Acid Type
  - DNA
  - RNA
- By Application
  - Drug Discovery
  - Therapeutics
- By End User
  - Academic Research Institutes
  - Diagnostic Laboratories
  - Pharmaceutical-Biotechnology Companies
- By Country:
  - GCC
  - Israel
  - Rest of Middle East
Africa
- By Equipment & Services
  - Equipment/Synthesizer
  - Reagents
  - Services
- By Technology
  - Column-based
  - Microarray-based
- By Nucleic Acid Type
  - DNA
  - RNA
- By Application
  - Drug Discovery
  - Therapeutics
- By End User
  - Academic Research Institutes
  - Diagnostic Laboratories
  - Pharmaceutical-Biotechnology Companies
- By Country/Region:
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
Thermo Fisher Scientific
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
Sigma-Aldrich Corporation
GE Healthcare
Integrated DNA Technologies, Inc.
TriLink BioTechnologies, Inc
BioAutomation Corporation
Twist Bioscience
Shanghai SynTheAll Pharmaceutical Co.
CUSABIO Technology LLC
Synbio Technologies
GENEWIZ
Eurofins Scientific
Agilent Technologies
Kaneka Eurogentec S.A.
LGC, Biosearch Technologies

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Equipment and Services
- Market Snippet, By Technology
- Market Snippet, By Nucleic Acid
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Test Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Oligonucleotide Synthesis Market, By Equipment and Services, 2021- 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Equipment and Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
  - Nucleic Acid Synthesizer
  - Peptide Synthesizer
Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
  - Oligo Synthesis
  - Modification
  - Purification

5. Global Oligonucleotide Synthesis Market, By Technology, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
ColuBn-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Microarray-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends

6. Global Oligonucleotide Synthesis Market, By Nucleic Acid, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
DNA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
RNA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends

7. Global Oligonucleotide Synthesis Market, By Application, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Drug Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends

8. Global Oligonucleotide Synthesis Market, By End User, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Academic Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Pharmaceutical-biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends

9. Global Oligonucleotide Synthesis Market, By Region, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Equipment and Services, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Nucleic Acid, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Equipment and Services, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Nucleic Acid, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Equipment and Services, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Nucleic Acid, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Equipment and Services, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Nucleic Acid, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Equipment and Services, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Nucleic Acid, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Equipment and Services, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Nucleic Acid, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2021 -2033, (US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

10. Competitive Landscape

Company Profiles
- Thermo Fisher Scientific Inc.*
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Merck KGaA
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Danaher Corporation
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Twist Bioscience
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- STA Pharmaceutical Co. Ltd.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- KINOVATE LIFE SCIENCES
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- CUSABIO TECHNOLOGY LLC
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Synbio Technologies
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- GENEWIZ
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Agilent Technologies, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Maravai LifeSciences Holdings, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Biogen
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Eurofins Scientific
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Sarepta Therapeutics, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- LGC Limited
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Kaneka Corporation
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Biotage
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Nitto Denko Corporation
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies